Wikidata

(Q62105261)

English

Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis

clinical trial

In more languages

Statements

short name
RNF (English)
0 references
title
A Multicentre, Single Arm, Open-Label, Phase IIIB Study to Evaluate the Safety and Antigenicity of Rebif® (Interferon-beta-1a) in Subjects With Relapsing Forms of Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
Merck KGaA
0 references
start time
January 2005
0 references
end time
April 2007
0 references
number of participants
260
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62105261&oldid=2139336905"